AK Medical Holdings Limited disclosed a repurchase of 30,000 ordinary shares on 22 September 2026 under its existing buyback mandate. The shares were repurchased on the Hong Kong Stock Exchange at a single price of HK $4.935 each, representing an aggregate consideration of approximately HK $0.15 million.

Following the transaction, the company is holding the repurchased shares as treasury stock, lifting its treasury-share balance from 32.52 million to 32.55 million. The total number of issued shares (excluding treasury shares) has been reduced marginally to 1.08 billion, a 0.0028% contraction versus the pre-transaction figure.

Repurchase capacity and restrictions: • Current mandate: 112.46 million shares authorized for buyback by the shareholders on 17 June 2026. • Cumulative usage: 48.11 million shares repurchased to date, equal to 4.28% of the issued share base when the mandate was granted. • Moratorium: In accordance with Hong Kong listing rules, AK Medical is restricted from issuing new shares or transferring treasury shares until 22 October 2026.

The board confirmed that the repurchase complied with all applicable listing rules and legal requirements, and that payment has been duly settled.